Addendum

Cabozantinib (hepatocellular carcinoma) - Second Addendum to Commission A18-85

Report documents

2019-06-06 A G-BA decision was published.

Project no.: G19-11
Commission: Commission awarded on 24.04.2019 by the Federal Joint Committee (GBA).
Report type: Addendum
Status: Commission completed
Department/Division: Health Economics
Topic: Cancer
Note: If, in the course of the discussions on a commission of the G-BA, a need for further revision arises, IQWiG presents its report in the form of an addendum. The G-BA decides on the number of patients in the SHI target population.

Press contact

+49 221 356850

press@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.